With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment||Vanderbilt University Medical Center / John Wilson, PhD||'A' Award Grants||2015||Tennessee|
|Integrative Genomic and Immunogenomic Analysis of Neuroblastoma||University of California at Santa Cruz / David Haussler, PhD||Innovation Grants||2015||California|
|Molecular Annotation for Treatment of Childhood Cancers Trial: Neuroblastoma (MATCH-NB)||Children's Hospital of Philadelphia / Yael Mosse,M.D.||Bio-Therapeutic Impact Award||2015||Pennsylvania|
|Next-Generation Personalized Neuroblastoma Therapy (Nepenthe)||Children's Hospital of Philadelphia / Yael Mosse, MD & John Maris, MD||Bio-Therapeutic Impact Award||2015||Pennsylvania|
|Novel Nanoscale Phosphoproteomic Discovery of Therapeutic Targets in AML Stem Cells||Dana-Farber Cancer Institute / Leo Wang, MD, PhD||Young Investigator Grants||2015||Massachusetts|
|Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors||University of Florida / Catherine Flores, PhD||Young Investigator Grants||2015||Florida|
|Optimizing Bispecific Antibody Therapy for Acute Leukemias||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD & James Olson, MD, PhD||Innovation Grants||2015||Washington|
|Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma||Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP)||Innovation Grants||2015||Virginia|
|Phase I and II Clinical Research Program Infrastructure Award||University of Minnesota / Brenda Weigel, MD & Emily Greengard MD||Phase I/II Infrastructure Grants||2015||Minnesota|
|Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy||University of North Carolina / Timothy Gershon, MD, PhD||Innovation Grants||2015||North Carolina|